-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Edwards Lifesciences, Raises Price Target to $121

Benzinga·11/16/2026 13:55:11
Listen to the news
Wells Fargo analyst Larry Biegelsen maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $113 to $121.